Effect of pioglitazone on left ventricular diastolic function and fibrosis of type III collagen in type 2 diabetic patients

Journal of Cardiology

Volumn 54, Issue 1, 2009, Pages 52-58

  Terui, Gen ^a   Goto, Takashi ^a   Katsuta, Mitsuaki ^a   Aoki, Isamu ^a   Ito, Hiroshi ^b  

^a AKITA RED CROSS HOSPITAL   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Left ventricular diastolic function; Pioglitazone; Type III collagen

Indexed keywords

PIOGLITAZONE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIASTOLE; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HUMAN; MALE; MITRAL VALVE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; COLLAGEN TYPE III; DIABETES MELLITUS, TYPE 2; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MYOCARDIUM; THIAZOLIDINEDIONES; VENTRICULAR FUNCTION, LEFT;

EID: 67650720711     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.03.004     Document Type: Article

References (24)

1. Yamamoto K., Ohki R., Lee R.T., Ikeda U., and Shimada K. Peroxisome proliferator-activated receptor γ activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 104 (2001) 1670-1675
2. Kim S.K., Zhao Z.S., Lee Y.J., Lee K.E., Kang S.M., Choi D., Lim S.K., Chung N., Lee H.C., and Cha B.S. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-α or-γ agonists in a type 2 diabetic animal model. Diabetes Metab Res Rev 19 (2003) 487-493
3. Nissen S.E., Nicholls S.J., Wolski K., Nesto R., Kupfer S., Perez A., Jure H., De Larochellière R., Staniloae C.S., Mavromatis K., Saw J., Hu B., Lincoff A.M., and Tuzcu E.M. PERISCOPE Investigators. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA 299 (2008) 1561-1573
4. Dormandy J.A., Charbonnel B., Eckland D.J.A., Erdmann E., Massi-Benedetti M., Moules I.K., Skene A.M., Tan M.H., Lefèbvre P.J., Murray G.D., Standl E., Wilcox R.G., Wilhelmsen L., Betteridge J., Birkeland K., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactives study. Lancet 366 (2005) 1279-1289
5. Terui G., Goto T., Katsuta M., and A-oki I. Assessment of left ventricular diastolic function with pioglitazone in type 2 diabetic patients. J Cardiol 48 (2006) 263-267 [in Japanese]
6. Izawa H., Murohara T., Nagata K., Isobe S., Asano H., Amano T., Ichihara S., Kato T., Ohshima S., Murase Y., Iino S., Obata K., Noda A., Okumura K., and Yokota M. Mineralcorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy. Circulation 112 (2005) 2940-2945
7. Zannad F., Alla F., Dousset B., Perez A., and Pitt B. On behalf of the RALES investigators. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Circulation 102 (2000) 2700-2706
8. Poulsen S., Host N.B., Jensen S.E., and Egstrup K. Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation 101 (2000) 1527-1532
9. Martos R., Baugh J., Ledwidge M., O'Loughlin C., Conlon C., Patle A., Donnelly S.C., and McDonald K. Diastolic heart failure. Evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115 (2007) 888-895
10. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., Tajik A.J., and Seward J.B. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: A study in normals and dilated cardiomyopathy. J Cardiol 26 (1995) 357-366
11. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55 (1977) 613-618
12. Delerive P., Fruchart J.C., and Staels B. Peroxisome proliferators-activated receptors in inflammation control. J Endocrinol 169 (2001) 453-459
13. Tsuji T., Mizushige K., Noma T., Murakami K., Ohmori K., Miyatake A., and Kohno M. Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat. J Cardiovasc Pharmacol 38 (2001) 868-874
14. Caglayan E., Stauber B., Collins A.R., Lyon C.J., Yin F., Liu J., Rosenkranz S., Erdmann E., Peterson L.E., Ross R.S., Tangirala R.K., and Hsueh W.A. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor γ in cardiac fibrosis. Diabetes 57 (2008) 2470-2479
15. Langenfeld M.R., Forst T., Hohberg C., Kann P., Lubben G., Konrad T., Füllert S.D., Sachara C., and Pfützner A. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus. Circulation 111 (2005) 2525-2531
16. Pfutzner A., Marx N., Lubben G., Langenfeld M., Walcher D., Konrad T., and Forst T. Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control. J Am Coll Cardiol 45 (2005) 1925-1931
17. Wang C.H., Weisel R.D., Liu P.P., Fedak P.W.N., and Verma S. Glitazones and heart failure Critical appraisal for clinician. Circulation 107 (2003) 1350-1354
18. Masoudi F.A., Inzucchi S.E., Wang Y., Havranek E.P., Foody J.M., and Krumholz H.M. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure. Circulation 111 (2005) 583-590
19. Eurich D.T., Majumdar S.R., McAlister F.A., Tsuyuki R.T., and Johnson J.A. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 28 (2005) 2345-2351
20. Yki-Jarvinen H. Drug therapy. Thiazolidinediones. N Engl J Med 351 (2004) 1106-1118
21. Chapman D., Weber K.T., and Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overload rat myocardium. Circ Res 67 (1990) 787-794
22. Montes G.S., and Junqueira L.C.U. Biology of collagen. Rev Can Biol Exp 41 (1982) 143-156
23. Sassa S., Shimada K., Yoshida K., Tanaka H., Jissho S., and Yoshikawa J. Comparison of 64-slice multi-detector computed tomography coronary angiography between asymptomatic, type 2 diabetes mellitus and impaired glucose tolerance patients. J Cardiol 52 (2008) 133-139
24. Sohn D.W., Chai I.H., Lee D.J., Kim H.C., Kim H.S., Oh B.H., Lee M.M., Park Y.B., Choi Y.S., Seo J.D., and Lee Y.W. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30 (1997) 474-480